- Correction
- Open access
- Published:
Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
BMC Cancer volume 21, Article number: 361 (2021)
Correction to: BMC Cancer 21, 321 (2021)
https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-021-08056-4
Following publication of the original article [1], the authors reported a typesetting error. Figures 4 and 5 were transposed. The correct Figs. 4 and 5 are supplied below and the original article [1] has been corrected.
Reference
Huang CC, Liu FR, Feng Q, et al. RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480. BMC Cancer. 2021;21:321 https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-021-08056-4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Huang, CC., Liu, FR., Feng, Q. et al. Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480. BMC Cancer 21, 361 (2021). https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-021-08120-z
Published:
DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-021-08120-z